type in your search and press enter
OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial
You May Also Like
Calithera Biosciences to Present at Cowen and Company 37th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...
Loxo Oncology Announces Larotrectinib Clinical Update in Patients with TRK Fusion Cancers at the European Society for Medical Oncology 2018 Congress
- Median Duration of Response Not Reached With One Year of Additional Follow-up - ...
Horizon Pharma plc Increases Peak Net Sales Guidance for Key Growth Drivers and Announces Rheumatology and Orphan Pipeline Developments
-- Increases KRYSTEXXA®(pegloticase injection) Estimated Peak Annual Net Sales to more than $750 Million ...